Advancements in diabetes treatment, public health safety, and neurological research headline today's medical news.

The FDA has approved Awiqli, a new once-weekly basal insulin from Novo Nordisk, marking a major development for adults living with type 2 diabetes.

The FDA finalized new guidance for the fresh-cut produce industry, emphasizing stricter sanitation and supplier oversight to mitigate risks of contamination.

A Devon hospital has been forced to suspend its birthing services due to severe staffing shortages, highlighting a broader workforce crisis within the UK midwifery sector.

Research indicates that depressive symptoms mediate the relationship between cerebral amyloid angiopathy (CAA) and cognitive decline, suggesting a link between psychological health and vascular brain conditions.

A new study finds that late-onset temporal lobe epilepsy presents with distinct cognitive and biomarker patterns, differentiating it clinically from Alzheimer disease.

Implementation of simple, automated reminders for both primary care providers and patients has been shown to significantly improve adherence to annual lung cancer screening programs.

Eye doctors in the UK are issuing health warnings to the public to prevent vision damage during the upcoming solar eclipse, which will obscure up to 96 percent of the sun.

Manufacturing difficulties have stalled the regulatory approval process for the radioligand therapy 177Lu-edotreotide, though the manufacturer remains committed to resolving the production issues.